© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
October 16, 2013
Patients with advanced Alzheimer's disease treated with 13.3 mg rivastigmine patch showed greater improvements in cognitive, functional, and behavioral performance from baseline compared to patients who received 4.6 mg patches.
Despite current guideline recommendations against the use of routine neuroimaging for uncomplicated headaches, physicians still tend to order imaging tests for many patients who present with headache and migraine, driving up annual healthcare spending.
Study results show that patients who received combination treatment demonstrated improvements in cognition, function, and behavioral outcomes compared to treatment with either medication alone or placebo.
October 15, 2013
Patients with advanced Parkinson's disease treated with an investigational extended-release carbidopa-levodopa formulation experienced greater reductions in "off" time and greater improvement in dyskinesia-free "on" time compared with similar patients treated with carbidopa-levodopa plus entacapone.